Do you want to invest??
Want to Invest in Defensive sector?
Want to invest with a long term view?
This article could give you an answer. Pharma sector is such space which is less volatile as compared to Nifty & perform well in a long run as what the past tell us & what lies in the store for pharma space in future & the best pick in the pharma space is Lupin
Pharma Analysts believe the current crises in Japan could benefit Lupin, which has introduced 10 new generic drugs. So, 12% of the company's revenue comes from Japanese subsidiaries. Now, looking at the tsunami in Japan, there will be a lot of generic drugs for Lupin & its subsidiaries in Japan.
Lupin as compared to its peers like Cadila Healthcare, GSK Pharma, Ranbaxy, Cipla; Lupin seems to be much better placed in terms of market valuations & future pospects of the company & Management of the Company
One can buy the stock at the CMP at 385, with a price target of Rs 600 in next 1 year
Regards
Mayank Gupta
Long Term Investment Mumbai
Wealth Bazaar.in
Want to Invest in Defensive sector?
Want to invest with a long term view?
This article could give you an answer. Pharma sector is such space which is less volatile as compared to Nifty & perform well in a long run as what the past tell us & what lies in the store for pharma space in future & the best pick in the pharma space is Lupin
Pharma Analysts believe the current crises in Japan could benefit Lupin, which has introduced 10 new generic drugs. So, 12% of the company's revenue comes from Japanese subsidiaries. Now, looking at the tsunami in Japan, there will be a lot of generic drugs for Lupin & its subsidiaries in Japan.
Lupin as compared to its peers like Cadila Healthcare, GSK Pharma, Ranbaxy, Cipla; Lupin seems to be much better placed in terms of market valuations & future pospects of the company & Management of the Company
One can buy the stock at the CMP at 385, with a price target of Rs 600 in next 1 year
Regards
Mayank Gupta
Long Term Investment Mumbai
Wealth Bazaar.in
No comments:
Post a Comment